サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1559676

腸疾患検査の世界市場

Enteric Disease Testing

出版日
ページ情報
英文 158 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.58円
腸疾患検査の世界市場
出版日: 2024年09月24日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 158 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

腸疾患検査の世界市場は2030年までに31億米ドルに到達

2023年に22億米ドルと推定される腸疾患検査の世界市場は、2023年から2030年にかけてCAGR 4.8%で成長し、2030年には31億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである細菌腸疾患検査は、CAGR 4.8％を記録し、分析期間終了までに18億米ドルに達すると予測されます。寄生虫腸疾患検査分野の成長率は、分析期間中CAGR 4.1％と推定されます。

米国市場は5億8,720万米ドル、中国はCAGR 7.1％で成長予測

米国の腸疾患検査市場は、2023年に5億8,720万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR7.1％を追いかけ、2030年までに6億5,750万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.6%と4.4%と予測されています。欧州では、ドイツがCAGR 2.7%で成長すると予測されています。

世界の腸疾患検査市場- 主要動向と促進要因のまとめ

腸疾患検査は公衆衛生と疾病管理にどのような革命をもたらしているか？

腸疾患検査は、消化管に影響を及ぼす感染症を診断するための迅速、正確かつ包括的なツールを提供することで、公衆衛生と疾病管理に革命をもたらしています。細菌、ウイルス、寄生虫によって引き起こされる腸管疾患は、特に清潔な水や衛生設備へのアクセスが限られている地域では、世界的に重大な健康問題です。これらの病気は、特に子どもや高齢者など社会的弱者の間で、深刻な脱水症状や栄養失調を引き起こし、場合によっては死に至ることもあります。腸管感染症を迅速かつ正確に診断する能力は、効果的な治療、封じ込め、発生予防のために極めて重要です。最新の腸疾患検査は、分子アッセイ、イムノアッセイ、次世代シークエンシングなどの高度な診断技術を活用し、幅広い病原体を高い感度と特異性で検出します。ヘルスケアプロバイダーが消化器症状の正確な原因を迅速に特定できるようにすることで、腸疾患検査は患者の予後を改善し、感染症の蔓延を抑え、世界中の腸疾患の制御と予防を目的とした公衆衛生イニシアチブを支援しています。

どのようなイノベーションが腸疾患検査の機能を向上させていますか？

腸疾患検査のイノベーションは、分子診断、ポイントオブケア検査、マルチプレックス検査プラットフォームの進歩を通じて、その機能性を高めています。最も重要な進歩のひとつは、ポリメラーゼ連鎖反応（PCR）およびその他の核酸増幅技術の使用です。これらの分子診断法は、便検体中の特定の細菌、ウイルス、寄生虫を数時間以内に同定することができます。分子診断のスピードと精度は、集団発生を管理し、患者が適切な治療を迅速に受けられるようにすることで、合併症やトランスミッションのリスクを低減する上で特に有用です。

ポイント・オブ・ケア検査（POCT）もまた、腸疾患診断に変革をもたらす重要な技術革新です。POCT検査機器は、ベッドサイドや遠隔地で使用できるように設計されており、専門的な検査機器を必要とせずに即時に結果を得ることができます。このようなポータブルで使いやすい機器は、従来の検査インフラへのアクセスが乏しい、資源の限られた地域では特に有益です。POCTは、現場での腸疾患の迅速な診断と治療を可能にし、治療までの時間を短縮し、予後を改善します。この技術革新は、原因病原体をタイムリーに特定することで病気の蔓延を防ぐことができるアウトブレイク状況においても重要です。

マルチプレックス検査プラットフォームは、腸疾患検査におけるもう一つの大きな進歩です。これらのシステムは1つのサンプルから複数の病原体を同時に検出することができ、消化器症状の潜在的な原因を包括的に分析することができます。マルチプレックス検査は、食中毒の発生や免疫不全患者など、様々な病原体によって症状が引き起こされる可能性がある場合に特に有用です。マルチプレックス検査は、広範な診断ツールを提供することで、複数の個別検査の必要性を減らし、時間とリソースを節約すると同時に、患者の状態を徹底的に調査することができます。

このような技術革新により、腸疾患検査はより迅速で正確、かつ利用しやすいものとなり、効果的な疾病管理と公衆衛生の保護に不可欠なものとなっています。

腸疾患検査は公衆衛生と患者の転帰にどのような影響を与えていますか？

腸疾患検査は、消化器系に影響を及ぼす感染症のタイムリーな診断、治療、予防を可能にすることで、公衆衛生と患者の転帰に大きな影響を与えます。個々の患者にとって、正確で迅速な検査は、病気の原因となる特定の病原体を特定し、適切な治療の指針とするために極めて重要です。適切な診断がなされなければ、患者は効果のない、あるいは不適切な治療を受けることになり、病気の長期化、合併症のリスクの増大、ヘルスケアコストの増大を招く。腸疾患検査によって、的を絞った治療が可能になり、病気の期間と重症度を軽減し、特に小児や高齢者のような脆弱な集団において、脱水などの合併症の可能性を最小限に抑えることができます。

公衆衛生の観点からは、腸疾患検査は感染症の蔓延を抑えるために不可欠です。地域社会で発生した感染症の病原体を迅速に特定することで、公衆衛生当局は感染者の隔離、公衆への警告、汚染源の追跡などの封じ込め対策をより効果的に実施することができます。食中毒の場合、迅速な検査によって汚染された食品を特定することができ、さらなる感染者を防ぎ、公衆衛生を守ることができます。さらに、腸疾患検査から生成されたデータは、サーベイランス活動にも貢献し、疾病発生動向の追跡、新興病原体の監視、公衆衛生介入の有効性の評価に役立ちます。

腸疾患検査はまた、特に消化器感染症の負担が大きい地域において、世界ヘルスに重要な役割を果たしています。清潔な水や衛生設備へのアクセスが制限されている地域では、腸疾患は罹患率や死亡率の主な原因となっています。早期発見と治療に必要なツールを提供することで、腸疾患検査はこれらの病気の負担を軽減し、脆弱な人々の健康状態を改善するための幅広い取り組みを支援します。さらに、迅速で正確な検査が可能であることは、難民キャンプなどの人道的な環境において極めて重要です。そこでは、腸疾患の流行が急速に広がり、壊滅的な結果をもたらす可能性があります。

全体として、腸疾患検査が公衆衛生に与える影響は広範囲に及び、患者の転帰を改善し、疾病管理努力を強化し、将来のアウトブレイクの予防に貢献します。

腸疾患検査市場の成長を促進する動向は？

食中毒の発生率の増加、診断技術の進歩、迅速検査ソリューションに対する需要の高まり、感染症の制御を目的とした世界の公衆衛生への取り組みなど、いくつかの動向が腸疾患検査市場の成長を促進しています。食中毒の発生率の増加は、腸疾患検査の需要を煽る重要な要因です。食品サプライチェーンの世界化が進むにつれて、汚染された食品に起因するアウトブレイクが広範に発生するリスクが高まっており、食品の安全性がより重視されるようになり、そのようなアウトブレイクを迅速に特定し封じ込めるための信頼性の高い検査方法の必要性が高まっています。

診断技術、特に分子診断技術の進歩も腸疾患検査市場の成長に寄与しています。より速く、より正確で、費用対効果の高い診断ツールの開発により、腸疾患検査の利用可能性とアクセス性が拡大しました。PCRベースのアッセイ、次世代シーケンシング、マルチプレックス・プラットフォームなどの技術革新により、リソースの少ない環境においても、複数の病原体を同時に高い感度と特異性で検出することが可能になりました。こうした進歩は、患者の治療を改善するだけでなく、サーベイランスやアウトブレイク対応に不可欠なデータを提供することで、より広範な公衆衛生の取り組みを支援しています。

迅速検査ソリューションに対する需要の高まりも、市場成長を促進する重要な動向です。臨床と公衆衛生の両方の場面で、迅速な治療と介入を可能にする結果を迅速に提供できる診断検査に対するニーズが高まっています。このような需要は、病気の蔓延を防ぎ人命を救うためにタイムリーな診断が不可欠な、感染症発生や自然災害などの緊急事態において特に顕著です。現場で迅速かつ正確な結果を提供するポイント・オブ・ケア検査機器の開発と配備は、このニーズに応え、さまざまな環境での採用を促進しています。

特に低・中所得国における腸疾患の負担軽減を目指した世界の公衆衛生イニシアチブも、腸疾患検査市場の成長を後押ししています。世界保健機関（WHO）や疾病対策予防センター（CDC）などの組織は、診断へのアクセスを改善し、疾病監視システムを強化し、アウトブレイクへの迅速な対応能力を強化するためのプログラムに投資しています。このような取り組みにより、これらの目標をサポートする高度な腸疾患検査ソリューションに対する需要が高まっています。

さらに、抗菌薬耐性（AMR）への注目が腸疾患検査市場に影響を与えています。抗生物質の誤用や耐性病原体の増加に対する懸念が高まる中、適切な治療を確実に行うための正確な診断がますます重視されるようになっています。原因となる病原体とその耐性プロファイルを迅速に特定できる腸疾患検査は、AMRとの闘いに不可欠なものとなっています。

これらの動向は、公衆衛生の向上、疾病管理の強化、感染症がもたらす課題への対応において、腸疾患検査が果たす重要な役割を浮き彫りにしています。腸疾患検査が世界のヘルスケアに欠かせない存在であり続けるために、検査技術の革新と世界ヘルスへの取り組みが、市場のさらなる成長と開拓の原動力となるでしょう。

調査対象企業の例（全12件）

  • Apollo Diagnostics
  • bioMerieux Sweden AB
  • Centre for Infectious Disease Research in Zambia（CIDRZ）
  • EntroGen, Inc.
  • Genovate Laboratories Inc.
  • Quest Diagnostics, Inc.
  • TECHLAB, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP11810

Global Enteric Disease Testing Market to Reach US$3.1 Billion by 2030

The global market for Enteric Disease Testing estimated at US$2.2 Billion in the year 2023, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Bacterial Enteric Disease Testing, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Parasitic Enteric Disease Testing segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$587.2 Million While China is Forecast to Grow at 7.1% CAGR

The Enteric Disease Testing market in the U.S. is estimated at US$587.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$657.5 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Enteric Disease Testing Market - Key Trends and Drivers Summarized

How Is Enteric Disease Testing Revolutionizing Public Health and Disease Management?

Enteric disease testing is revolutionizing public health and disease management by providing rapid, accurate, and comprehensive tools for diagnosing infections that affect the gastrointestinal tract. Enteric diseases, caused by bacteria, viruses, or parasites, are a significant global health concern, particularly in areas with limited access to clean water and sanitation. These diseases can lead to severe dehydration, malnutrition, and, in some cases, death, especially among vulnerable populations such as children and the elderly. The ability to quickly and accurately diagnose enteric infections is critical for effective treatment, containment, and prevention of outbreaks. Modern enteric disease testing leverages advanced diagnostic technologies, including molecular assays, immunoassays, and next-generation sequencing, to detect a wide range of pathogens with high sensitivity and specificity. By enabling healthcare providers to identify the exact cause of gastrointestinal symptoms promptly, enteric disease testing is improving patient outcomes, reducing the spread of infections, and supporting public health initiatives aimed at controlling and preventing enteric diseases worldwide.

What Innovations Are Enhancing the Functionality of Enteric Disease Testing?

Innovations in enteric disease testing are enhancing its functionality through advancements in molecular diagnostics, point-of-care testing, and multiplex testing platforms. One of the most significant developments is the use of polymerase chain reaction (PCR) and other nucleic acid amplification techniques, which allow for the rapid detection of genetic material from pathogens with high accuracy. These molecular diagnostic methods can identify specific bacteria, viruses, and parasites in stool samples within hours, compared to traditional culture methods that may take days. The speed and precision of molecular diagnostics are particularly valuable in managing outbreaks and ensuring that patients receive the appropriate treatment quickly, thereby reducing the risk of complications and transmission.

Point-of-care testing (POCT) is another key innovation that is transforming enteric disease diagnostics. POCT devices are designed for use at the bedside or in remote settings, providing immediate results without the need for specialized laboratory equipment. These portable, easy-to-use devices are particularly beneficial in resource-limited areas where access to traditional laboratory infrastructure may be lacking. POCT allows for the rapid diagnosis and treatment of enteric diseases in the field, reducing the time to care and improving the chances of a successful outcome. This innovation is also critical in outbreak situations, where timely identification of the causative pathogen can prevent the spread of disease.

Multiplex testing platforms represent another major advancement in enteric disease testing. These systems can simultaneously detect multiple pathogens from a single sample, providing a comprehensive analysis of potential causes of gastrointestinal symptoms. Multiplex tests are particularly useful in cases where symptoms could be caused by a variety of pathogens, such as in foodborne illness outbreaks or in immunocompromised patients. By providing a broad-spectrum diagnostic tool, multiplex testing reduces the need for multiple individual tests, saving time and resources while ensuring a thorough investigation of the patient’s condition.

These innovations are making enteric disease testing more rapid, accurate, and accessible, which is crucial for effective disease management and the protection of public health.

How Does Enteric Disease Testing Impact Public Health and Patient Outcomes?

Enteric disease testing has a profound impact on public health and patient outcomes by enabling the timely diagnosis, treatment, and prevention of infections that affect the gastrointestinal system. For individual patients, accurate and rapid testing is critical for identifying the specific pathogen responsible for their illness, which guides appropriate treatment. Without proper diagnosis, patients may receive ineffective or inappropriate treatments, leading to prolonged illness, increased risk of complications, and higher healthcare costs. Enteric disease testing allows for targeted therapy, reducing the duration and severity of the illness and minimizing the potential for complications such as dehydration, especially in vulnerable populations like children and the elderly.

From a public health perspective, enteric disease testing is essential for controlling the spread of infectious diseases. Rapid identification of pathogens in community outbreaks allows public health authorities to implement containment measures more effectively, such as isolating infected individuals, issuing public warnings, and tracing the source of contamination. In the case of foodborne illnesses, prompt testing can lead to the identification of contaminated food products, preventing further cases and protecting public health. Moreover, the data generated from enteric disease testing contribute to surveillance efforts, helping to track trends in disease incidence, monitor emerging pathogens, and evaluate the effectiveness of public health interventions.

Enteric disease testing also plays a vital role in global health, particularly in regions with high burdens of gastrointestinal infections. In areas where access to clean water and sanitation is limited, enteric diseases are a leading cause of morbidity and mortality. By providing the tools needed for early detection and treatment, enteric disease testing helps to reduce the burden of these diseases and supports broader efforts to improve health outcomes in vulnerable populations. Additionally, the availability of rapid and accurate testing is crucial in humanitarian settings, such as refugee camps, where outbreaks of enteric diseases can spread quickly and have devastating consequences.

Overall, the impact of enteric disease testing on public health is far-reaching, improving patient outcomes, enhancing disease control efforts, and contributing to the prevention of future outbreaks.

What Trends Are Driving Growth in the Enteric Disease Testing Market?

Several trends are driving growth in the enteric disease testing market, including the increasing incidence of foodborne illnesses, advancements in diagnostic technology, the rising demand for rapid testing solutions, and global public health initiatives aimed at controlling infectious diseases. The growing incidence of foodborne illnesses is a significant factor fueling the demand for enteric disease testing. As globalization of the food supply chain increases, the risk of widespread outbreaks caused by contaminated food products has risen, prompting greater emphasis on food safety and the need for reliable testing methods to quickly identify and contain such outbreaks.

Advancements in diagnostic technology, particularly in molecular diagnostics, are also contributing to the growth of the enteric disease testing market. The development of faster, more accurate, and cost-effective diagnostic tools has expanded the availability and accessibility of enteric disease testing. Innovations such as PCR-based assays, next-generation sequencing, and multiplex platforms have made it possible to detect multiple pathogens simultaneously with high sensitivity and specificity, even in low-resource settings. These advancements are not only improving patient care but also supporting broader public health efforts by providing essential data for surveillance and outbreak response.

The rising demand for rapid testing solutions is another key trend driving market growth. In both clinical and public health settings, there is a growing need for diagnostic tests that can deliver results quickly, allowing for prompt treatment and intervention. This demand is particularly acute in emergency situations, such as outbreaks or natural disasters, where timely diagnosis is critical to preventing the spread of disease and saving lives. The development and deployment of point-of-care testing devices that provide rapid, accurate results in the field are meeting this need and driving adoption in diverse settings.

Global public health initiatives aimed at reducing the burden of enteric diseases, particularly in low- and middle-income countries, are also driving growth in the enteric disease testing market. Organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) are investing in programs to improve access to diagnostics, strengthen disease surveillance systems, and enhance the capacity for rapid response to outbreaks. These efforts are increasing the demand for advanced enteric disease testing solutions that can support these goals.

Additionally, the focus on antimicrobial resistance (AMR) is influencing the enteric disease testing market. With the growing concern over the misuse of antibiotics and the rise of resistant pathogens, there is an increasing emphasis on accurate diagnosis to ensure appropriate treatment. Enteric disease testing that can rapidly identify the causative pathogen and its resistance profile is becoming essential in the fight against AMR.

These trends highlight the critical role of enteric disease testing in improving public health, enhancing disease management, and responding to the challenges posed by infectious diseases. As the market continues to evolve, innovations in testing technology and global health initiatives will likely drive further growth and development, ensuring that enteric disease testing remains a vital component of healthcare worldwide.

Select Competitors (Total 12 Featured) -

  • Apollo Diagnostics
  • bioMerieux Sweden AB
  • Centre for Infectious Disease Research in Zambia (CIDRZ)
  • EntroGen, Inc.
  • Genovate Laboratories Inc.
  • Quest Diagnostics, Inc.
  • TECHLAB, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Enteric Disease Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Global Prevalence of Enteric Diseases Spurs Demand for Rapid Diagnostic Tests
    • Growing Travel and Migration Contributing to Spread of Enteric Pathogens
    • Integration of Point-of-Care Testing Devices in Remote and Resource-Limited Settings
    • Rising Healthcare Infrastructure Investments in Emerging Economies
    • Market Trends Towards Multiplexed Testing Platforms for Simultaneous Detection
    • Future Trends: AI and Machine Learning Integration in Diagnostic Processes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Bacterial Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Bacterial Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Bacterial Enteric Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Viral Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Viral Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Viral Enteric Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Parasitic Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Parasitic Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Parasitic Enteric Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Conventional Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Conventional Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Conventional Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Molecular Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Molecular Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Molecular Diagnostic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Testing Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Enteric Disease Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Enteric Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • JAPAN
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • CHINA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • EUROPE
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Enteric Disease Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • GERMANY
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Enteric Disease Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • INDIA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Enteric Disease Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Enteric Disease Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • AFRICA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030

IV. COMPETITION